Article
Glypican-3-deficient mice exhibit developmental overgrowth and some of the abnormalities typical of Simpson-Golabi-Behmel syndrome.
The Journal of cell biology - 12 Jul 1999
Cano-Gauci D F, Song H H, Yang H, McKerlie C, Choo B, Shi W, Pullano R, Piscione T D, Grisaru S, Soon S, Sedlackova L, Tanswell A K, Mak T W, Yeger H, Lockwood G A, Rosenblum N D, Filmus J
Abstract excerpt
Glypicans are a family of heparan sulfate proteoglycans that are linked to the cell surface through a glycosyl-phosphatidylinositol anchor. One member of this family, glypican-3 (Gpc3), is mutated in patients with the Simpson-Golabi-Behmel syndrome (SGBS). These patients display pre- and postnatal overgrowth, and a varying range of dysmorphisms. The clinical features of SGBS are very similar to the more...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
